KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Work In Process (2016 - 2026)

Abbott Laboratories' Work In Process history spans 18 years, with the latest figure at $994.0 million for Q1 2026.

  • On a quarterly basis, Work In Process rose 11.69% to $994.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $994.0 million, a 11.69% increase, with the full-year FY2025 number at $904.0 million, up 7.62% from a year prior.
  • Work In Process hit $994.0 million in Q1 2026 for Abbott Laboratories, up from $904.0 million in the prior quarter.
  • Over the last five years, Work In Process for ABT hit a ceiling of $994.0 million in Q1 2026 and a floor of $680.0 million in Q4 2022.
  • Historically, Work In Process has averaged $843.8 million across 5 years, with a median of $877.0 million in 2024.
  • Biggest five-year swings in Work In Process: fell 10.8% in 2022 and later grew 22.31% in 2023.
  • Tracing ABT's Work In Process over 5 years: stood at $680.0 million in 2022, then increased by 18.68% to $807.0 million in 2023, then increased by 4.09% to $840.0 million in 2024, then increased by 7.62% to $904.0 million in 2025, then increased by 9.96% to $994.0 million in 2026.
  • Business Quant data shows Work In Process for ABT at $994.0 million in Q1 2026, $904.0 million in Q4 2025, and $961.0 million in Q3 2025.